CVE-2022-2824Authorization Bypass Through User-Controlled Key in openemr/openemr
Updated under an hour ago ()
Does this affect you?
It affects openemr/openemr and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.75%, higher than 54% of scored CVEs.
Do this next
Free account, 1 product
Authorization Bypass Through User-Controlled Key in GitHub repository openemr/openemr prior to 7.0.0.1.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-639
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.75% (percentile 54)
- Assigned by
- @huntrdev
- NVD analysis
- Modified
- Record last updated
- Aug 3, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
openemr openemr/openemr openemr:openemr (from the name) | from unspecified before 7.0.0.1 | CNA record |
open-emr openemr open-emr:openemr | before 7.0.0.1 | NVD |
References
- https://huntr.dev/bounties/1ccb2d1c-6881-4813-a5bc-1603d29b7141x-refsource-confirm, exploit, third-party-advisory
- https://github.com/openemr/openemr/commit/c5d99452c173ef21a8e2241e2bbf4b66e2d7fe11x-refsource-misc, patch, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.